Cross-sectional study reveals differences in HPV vaccine uptake among adolescents, indicating the need for improved strategies.
This cross-sectional study examines state-level differences in human papillomavirus (HPV) vaccine uptake among adolescents aged 13 to 17 years.
No takes yet. Share an insight, caveat, or question.
Ejezie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: